Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

vTv Therapeutics (VTVT) Return on Equity (2016 - 2025)

vTv Therapeutics (VTVT) has disclosed Return on Equity for 11 consecutive years, with 0.46% as the latest value for Q4 2025.

  • Quarterly Return on Equity rose 105.0% to 0.46% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.46% through Dec 2025, up 105.0% year-over-year, with the annual reading at 0.81% for FY2025, 445.0% down from the prior year.
  • Return on Equity hit 0.46% in Q4 2025 for vTv Therapeutics, up from 0.78% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 2.94% in Q2 2022 to a low of 40.11% in Q1 2024.
  • Historically, Return on Equity has averaged 1.79% across 5 years, with a median of 0.18% in 2021.
  • Biggest five-year swings in Return on Equity: plummeted -4154bps in 2024 and later soared 3794bps in 2025.
  • Year by year, Return on Equity stood at 1.13% in 2021, then skyrocketed by 62bps to 1.84% in 2022, then tumbled by -43bps to 1.04% in 2023, then tumbled by -245bps to 1.51% in 2024, then soared by 69bps to 0.46% in 2025.
  • Business Quant data shows Return on Equity for VTVT at 0.46% in Q4 2025, 0.78% in Q3 2025, and 4.22% in Q2 2025.